RecruitingNCT03649503

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China (ForPDCN)


Sponsor

Huashan Hospital

Enrollment

100,000 participants

Start Date

Oct 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The overall goal of this project is to identify, assess and longitudinally monitor subjects who are interested in participating in this study. Participants will enroll through a platform named PaWei, and provide informed consent prior to any study activities. PaWei will collect a variety of information, including participants' demographic information, overall health, family history of Parkinson's Disease, other clinical information (clinical drug use, drug efficacy, and comorbid disorders), mood status, sleep, diet, exercise, memory complaints, online cognitive tests, the Short-Form 8-Item Parkinson's Disease Questionnaire (PDQ-8), Movement Disorder Society-Unified Parkinson's Disease Rating Scale IB \& II (MDS-UPDRS IB \& II), Non-Motor Symptom Aassessment Scale for Parkinson's Disease (NMSS) , Hoehn and Yahr Scale, and other scales related to quality of life, etal---all through self-reported online questionnaires. Participants will also be asked to return to the PaWei every 3 months at regular intervals, to complete follow-up scales related to quality of life, and neuropsychological assessments, etal. Anyone with Parkinsonian Disorders is welcome to participate.


Eligibility

Inclusion Criteria1

  • Anyone with Parkinsonian Disorders is welcome to join the Registry.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

Locations(2)

Huashan Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, China

Huashan Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03649503


Related Trials